Credit: Photodisc/Thinkstock    
Share on Facebook0Share on Google+0Tweet about this on Twitter0


Cancer Patient’s Family Uses Twitter to Fight Insurance Decision

Lorelei Decker’s Hodgkin lymphoma had resisted all other forms of treatment since she was first diagnosed with the cancer only a year ago, but she had renewed hope after discovering another promising cancer therapy option. When Lorelei was denied coverage by Blue Cross Blue Shield of Oklahoma, News OK reports that her family wasn’t about to take no for an answer.

“All hell's about to break loose,” tweeted Lorelei’s mother Andrea Decker. “BCBS DENIED Lorelei's transplant. No words for how angry I am. I guess it's cheaper to let her die.”

The family began an online campaign Tuesday afternoon for the 18-year-old using the hashtag #ApproveLorelei, and within an hour, they already had several Oklahoma residents tweet their support. By Wednesday afternoon, the insurance company had changed its mind and notified the family that Lorelei’s treatment would be covered.

“They can't just give people the runaround because the people they're giving the runaround are so tired of fighting cancer and so tired that they just feel defeated and quit,” Lorelei said. “And that's why this is never public — because it is so hard to fight cancer that it's too hard to fight insurance, too.”

Hilarie Houghton, a Blue Cross Blue Shield of Oklahoma spokeswoman, could not comment on the particular case due to Oklahoma laws regarding medical records, but did say that their doctors must “adhere to the plan certificates and regulatory guidelines that direct us regarding coverage decisions, determining what therapies are of proven efficacy, and evaluation of unusual therapies.”

We are so happy for Lorelei that her family’s unorthodox rally and petition worked so well, and we wish her the best of luck with her new treatment.

Source: News OK

Want more Wetpaint Moms? Like us on our Facebook page or follow us on Twitter!

03.9.2013 / 02:04 AM EDT by Emmalie Vance
Related: Moms, Health

Share on Facebook0Share on Google+0Tweet about this on Twitter0